Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
VTYX	VENTYX BIOSCIENCES INC	$644.37M	-48.10%	-43.90%	-53.25%	-50.70%	0.11	17.86	N/A	N/A	N/A
COYA	COYA THERAPEUTICS INC	$121.36M	-57.40%	-49.70%	-67.50%	-49,060.60%	0.17	8.73	100.00%	-462.30%	-480.32%
MGX	METAGENOMI INC	$60.83M	-43.20%	-31.10%	-41.23%	-34.60%	0.39	6.42	100.00%	-287.10%	-291.26%
CRBU	CARIBOU BIOSCIENCES INC	$148.61M	-80.80%	-62.70%	-94.14%	-69.20%	0.38	5.54	100.00%	-1,690.40%	-1,690.54%
XLO	XILIO THERAPEUTICS INC	$33.60M	-857.90%	-52.90%	-75.67%	265.00%	-17.52	2.20	100.00%	-183.90%	-183.90%
RVTY	REVVITY INC	$10.97B	3.10%	1.90%	3.38%	7.80%	0.65	1.75	55.30%	8.40%	13.10%
ACTU	ACTUATE THERAPEUTICS INC	$142.25M	-2,924.50%	-250.70%	-212.50%	311.00%	0.62	2.74	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$648.38M	-295.60%	-135.20%	-204.90%	-4,670.60%	1.09	1.80	100.00%	-2,273.90%	-2,271.65%
ROIV	ROIVANT SCIENCES LTD	$15.09B	-8.00%	-7.00%	-6.87%	-9.70%	0.06	33.71	96.40%	-1,839.60%	-1,665.46%
ALT	ALTIMMUNE INC	$376.36M	-54.80%	-47.60%	-40.73%	-92.80%	0.18	17.18	100.00%	-559,433.30%	-558,900.00%
ACOG	ALPHA COGNITION INC	$141.32M	-52.60%	-40.80%	-50.11%	-1,606.00%	0.37	6.69	73.10%	-262.20%	-266.30%
PASG	PASSAGE BIO INC	$37.51M	-102.10%	-53.00%	-87.19%	-120.00%	1.38	2.51	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$119.17M	-150.10%	-95.90%	-76.14%	728.50%	0.19	6.45	N/A	N/A	N/A
PEPG	PEPGEN INC	$447.55M	-84.10%	-65.60%	-53.08%	-125.70%	0.17	13.15	N/A	N/A	N/A
OMI	OWENS & MINOR INC	$216.57M	-1,259.50%	-30.30%	-78.24%	-44.10%	-10.40	0.86	26.10%	-20.00%	-18.32%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$97.54M	-51.50%	-40.00%	-51.54%	-45.80%	0.29	7.76	100.00%	368.10%	368.64%
ERAS	ERASCA INC	$1.06B	-33.10%	-27.80%	-32.60%	-31.00%	0.21	10.45	N/A	N/A	N/A
ALDX	ALDEYRA THERAPEUTICS INC	$311.64M	-72.20%	-47.90%	-83.73%	-130.90%	0.58	2.72	N/A	N/A	N/A
KZR	KEZAR LIFE SCIENCES INC	$46.06M	-62.50%	-51.80%	-71.92%	-77.80%	0.18	7.07	N/A	N/A	N/A
CTEV	CLARITEV CORP	$706.47M	N/A	-6.70%	-1.64%	-1.60%	-50.00	1.21	74.70%	-35.90%	-8.25%
ALLR	ALLARITY THERAPEUTICS INC	$17.08M	-112.00%	-64.90%	-125.80%	277.30%	0.73	2.33	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$1.95B	N/A	-86.70%	-48.87%	-21.30%	-1.99	5.77	99.60%	-422.30%	-273.40%
TLSA	TIZIANA LIFE SCIENCES LTD	$166.08M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
EQ	EQUILLIUM INC	$94.38M	-148.80%	-109.40%	-76.58%	1,073.10%	0.12	10.85	100.00%	-555.90%	-547.72%
HSDT	HELIUS MEDICAL TECHNOLOGIES INC	$119.36M	N/A	-301.80%	-78.20%	-423.30%	-4.12	40.03	49.60%	-39,358.90%	-39,291.07%
CTXR	CITIUS PHARMACEUTICALS INC	$16.13M	-57.90%	-29.90%	-41.98%	-54.50%	0.79	0.62	N/A	N/A	N/A
POAS	PHAOS TECHNOLOGY (CAYMAN) HOLDINGS LTD	N/A	-1,073.10%	-144.30%	275.47%	9,727.00%	-1.99	0.40	22.10%	-3,063.10%	-3,058.07%
PLRZ	POLYRIZON LTD	$8.32M	-12.40%	-11.70%	-18.72%	-3,440.00%	0.02	44.04	N/A	N/A	N/A
ACIU	AC IMMUNE SA	$316.81M	-83.50%	-35.80%	-97.78%	-248.70%	1.75	1.16	100.00%	-1,643.90%	-1,639.75%
SOPH	SOPHIA GENETICS SA	$316.85M	-93.90%	-46.60%	-54.45%	-109.90%	1.69	2.80	67.50%	-102.30%	-93.99%
PSTV	PLUS THERAPEUTICS INC	$70.09M	N/A	-172.50%	-334.59%	276.00%	2.69	1.29	100.00%	-391.30%	-321.61%
BFLY	BUTTERFLY NETWORK INC	$959.89M	-37.80%	-27.10%	-32.76%	-62.80%	0.42	4.80	43.20%	-90.30%	-88.76%
NCNA	NUCANA PLC	$0.00	-253.40%	-147.00%	-61.57%	750.70%	0.25	4.76	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$1.41M	N/A	N/A	N/A	N/A	0.08	8.09	N/A	N/A	N/A
SNSE	SENSEI BIOTHERAPEUTICS INC	$13.46M	-80.00%	-67.50%	-104.06%	-104.00%	0.20	5.81	N/A	N/A	N/A
SION	SIONNA THERAPEUTICS INC	$1.84B	-33.40%	-22.70%	-21.45%	-27.40%	0.06	25.61	N/A	N/A	N/A
RDY	DR REDDYS LABORATORIES LTD	$11.72B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
KALV	KALVISTA PHARMACEUTICALS INC	$816.32M	N/A	N/A	N/A	N/A	19.00	7.22	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$118.55M	-95.50%	-76.80%	-102.71%	-122.30%	0.27	4.64	N/A	N/A	N/A
GRDX	GRIDAI TECHNOLOGIES CORP	$15.67M	-888.30%	-16.40%	-4.86%	-9.10%	2.03	2.62	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.95B	-73.50%	-57.60%	-70.35%	-174.50%	0.64	5.66	100.00%	-1,266.00%	-1,264.37%
GERN	GERON CORP	$842.63M	-30.30%	-14.00%	-9.57%	-6.90%	1.28	5.96	97.70%	-43.60%	-25.04%
SDGR	SCHRODINGER INC	$1.32B	-48.20%	-24.20%	-34.32%	-39.30%	1.03	3.25	58.20%	-68.50%	-67.93%
NTRA	NATERA INC	$31.62B	-25.10%	-17.70%	-22.15%	-55.50%	0.46	3.27	63.70%	-14.60%	-14.43%
ALGS	ALIGOS THERAPEUTICS INC	$57.35M	-132.40%	-74.30%	-84.18%	-123.30%	0.53	4.70	100.00%	-3,267.60%	-2,792.71%
OCGN	OCUGEN INC	$421.63M	-491.20%	-99.20%	-163.12%	-157.50%	15.30	1.85	100.00%	-1,192.20%	-1,131.02%
RANI	RANI THERAPEUTICS HOLDINGS INC	$164.04M	N/A	-129.00%	273.69%	-132.60%	-2.81	0.26	100.00%	-2,359.60%	-2,053.83%
MLYS	MINERALYS THERAPEUTICS INC	$2.87B	-48.20%	-45.80%	-29.73%	-83.20%	0.04	25.50	N/A	N/A	N/A
MYNZ	MAINZ BIOMED NV	$4.58M	N/A	-207.80%	-508.89%	-2,883.90%	2.89	0.52	67.50%	-2,874.70%	-2,942.01%
GALT	GALECTIN THERAPEUTICS INC	$268.21M	N/A	-269.90%	24.43%	-70.60%	-1.09	0.09	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$271.49M	-67.40%	-65.30%	-33.21%	20,901.30%	0.04	23.98	N/A	N/A	N/A
TLPH	TALPHERA INC	$53.13M	-125.80%	-61.60%	-45.00%	-69.20%	0.60	6.83	100.00%	-44,242.90%	-44,242.86%
BNGO	BIONANO GENOMICS INC	$15.57M	-86.40%	-49.80%	-68.74%	-66.70%	0.59	2.12	46.00%	-134.40%	-134.24%
TWST	TWIST BIOSCIENCE CORP	$1.94B	-16.80%	-12.50%	-13.98%	-23.00%	0.36	3.64	50.70%	-20.60%	-20.43%
BRKR	BRUKER CORP	$7.16B	-1.20%	-0.40%	0.61%	0.70%	1.64	1.85	47.20%	-0.70%	0.91%
NAMS	NEWAMSTERDAM PHARMA CO NV	$3.98B	-29.10%	-26.90%	-30.36%	-211.70%	0.08	12.57	100.00%	-627.30%	-627.28%
SI	SHOULDER INNOVATIONS INC	$1.45B	N/A	N/A	N/A	N/A	0.20	11.09	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$1.61B	-31.20%	-29.30%	-24.11%	-50.10%	0.05	21.93	N/A	N/A	N/A
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$76.10M	-172.70%	-92.60%	-95.84%	-192.70%	0.32	2.21	73.00%	-2,251.50%	-2,195.46%
MBX	MBX BIOSCIENCES INC	$1.42B	-29.30%	-28.10%	-20.75%	-42.40%	0.03	32.96	N/A	N/A	N/A
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$214.98M	N/A	-128.00%	-167.23%	-955.80%	-5.78	2.79	54.70%	-1,380.70%	-1,378.12%
BNTC	BENITEC BIOPHARMA INC	$456.12M	-45.90%	-44.00%	-41.64%	2,647.30%	0.03	46.95	N/A	N/A	N/A
TOI	ONCOLOGY INSTITUTE INC	$350.24M	N/A	-36.70%	-51.13%	-32.30%	-14.33	1.68	14.80%	-13.10%	-10.87%
EVMN	EVOMMUNE INC	$539.69M	N/A	N/A	N/A	N/A	-0.06	7.87	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$552.98M	-47.40%	-38.10%	-43.51%	-245.30%	0.32	15.42	N/A	N/A	N/A
OPK	OPKO HEALTH INC	$967.30M	-13.70%	-8.70%	-2.63%	-5.60%	0.53	3.70	35.30%	-28.10%	-7.49%
ZLAB	ZAI LAB LTD	$1.95B	-25.80%	-17.70%	-25.28%	-96.60%	0.53	2.87	61.30%	-46.80%	-45.75%
VYGR	VOYAGER THERAPEUTICS INC	$218.51M	-48.90%	-37.40%	-49.86%	-45.70%	0.31	6.19	100.00%	-404.80%	-402.55%
IBIO	IBIO INC	$43.40M	-83.60%	-62.80%	-34.28%	-171.80%	0.15	8.40	100.00%	-4,021.60%	-3,983.40%
OGI	ORGANIGRAM GLOBAL INC	$225.89M	-6.80%	-4.60%	-8.84%	-14.60%	0.61	2.26	34.80%	-9.60%	-14.87%
STOK	STOKE THERAPEUTICS INC	$1.81B	13.30%	11.40%	8.62%	16.40%	0.17	6.53	100.00%	19.70%	13.35%
ALMS	ALUMIS INC	$1.02B	-75.50%	-57.60%	-60.04%	-105.60%	0.27	6.01	100.00%	-1,108.20%	-1,146.94%
KPTI	KARYOPHARM THERAPEUTICS INC	$125.49M	N/A	-101.10%	-883.59%	-45.00%	-1.36	1.03	95.90%	-87.40%	-56.26%
AIRS	AIRSCULPT TECHNOLOGIES INC	$123.62M	-21.80%	-9.00%	-9.08%	-10.60%	1.26	0.51	58.90%	-11.40%	-9.32%
CNTA	CENTESSA PHARMACEUTICALS PLC	$3.36B	-67.70%	-47.50%	-54.43%	-51.00%	0.49	10.57	100.00%	-1,618.00%	-1,521.18%
EDIT	EDITAS MEDICINE INC	$200.12M	-348.50%	-78.60%	-143.62%	-160.90%	14.00	2.86	100.00%	-430.80%	-433.42%
BDMD	BAIRD MEDICAL INVESTMENT HOLDINGS LTD	$36.11M	-8.50%	-4.50%	-2.19%	-1.60%	1.16	1.71	86.90%	-10.00%	-2.85%
FATE	FATE THERAPEUTICS INC	$113.39M	-56.60%	-40.20%	-49.47%	-40.10%	0.47	7.87	100.00%	-2,187.10%	-2,187.11%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$246.29M	-33.30%	-28.40%	-32.73%	-29.60%	0.19	14.96	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$183.95M	-55.20%	-49.90%	-42.88%	-210.80%	0.09	9.89	34.30%	-963.40%	-963.38%
MDXH	MDXHEALTH SA	$17.67M	-1,078.00%	-20.00%	-11.21%	-8.80%	-19.67	1.14	64.50%	-30.50%	-11.21%
SLGL	SOL-GEL TECHNOLOGIES LTD	$117.39M	N/A	N/A	N/A	N/A	0.33	5.15	N/A	N/A	N/A
MPLT	MAPLIGHT THERAPEUTICS INC	$796.98M	N/A	N/A	N/A	N/A	-0.09	13.22	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$612.08M	-32.20%	-30.00%	-34.99%	-38.20%	0.08	17.70	N/A	N/A	N/A
GOSS	GOSSAMER BIO INC	$717.51M	N/A	-59.70%	-100.61%	-38.50%	-3.54	3.28	100.00%	-354.50%	-335.05%
HTFL	HEARTFLOW INC	$2.48B	N/A	N/A	N/A	N/A	0.43	8.66	N/A	N/A	N/A
HYPR	HYPERFINE INC	$95.13M	-103.90%	-80.50%	-127.79%	-353.30%	0.55	3.63	46.10%	-378.20%	-378.17%
INMB	INMUNE BIO INC	$41.47M	-172.00%	-134.50%	-191.87%	1,346.60%	0.31	4.17	100.00%	-99,774.00%	-99,774.00%
LUNG	PULMONX CORP	$91.16M	-77.60%	-37.90%	-45.97%	-50.10%	1.30	4.86	73.30%	-61.90%	-57.87%
RCUS	ARCUS BIOSCIENCES INC	$2.57B	-68.20%	-31.30%	-44.93%	-44.90%	1.23	3.65	100.00%	-142.10%	-138.33%
TLSI	TRISALUS LIFE SCIENCES INC	$348.75M	N/A	-214.90%	-134.68%	-97.00%	-2.36	3.06	84.00%	-174.20%	-85.60%
KYMR	KYMERA THERAPEUTICS INC	$5.60B	-33.40%	-28.60%	-28.61%	-33.60%	0.17	7.38	100.00%	-674.80%	-674.04%
CARL	CARLSMED INC	$328.42M	N/A	N/A	N/A	N/A	0.26	12.03	N/A	N/A	N/A
SAVA	CASSAVA SCIENCES INC	$95.65M	-95.80%	-75.30%	-129.80%	2,002.20%	0.59	2.27	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$534.32M	-30.60%	-29.20%	-33.62%	-32.80%	0.06	18.71	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$955.12M	-48.90%	-42.50%	-30.07%	-58.90%	0.10	17.82	N/A	N/A	N/A
SRTS	SENSUS HEALTHCARE INC	$65.37M	-5.70%	-5.00%	-9.08%	-14.60%	0.14	7.38	48.00%	-8.40%	-13.13%
PSNL	PERSONALIS INC	$706.88M	-38.30%	-28.30%	-35.67%	-37.50%	0.42	4.82	26.70%	-106.90%	-106.69%
APVO	APTEVO THERAPEUTICS INC	$8.83M	-411.10%	-168.00%	-123.81%	-519.70%	0.55	4.03	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$611.44M	-42.10%	-39.80%	-48.01%	-49.30%	0.07	10.45	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	615	+0.27%	-2.56%	+0.97%	-41.73%	146.65x	5.25x	-24.86%	-9.63%	-5.94%	+53.28%	Strong Buy
Diagnostics & Research	57	-0.98%	-1.53%	-3.92%	+15.95%	22.62x	4.43x	-1.14%	+6.19%	+13.13%	+8.73%	Buy
Drug Manufacturers - General	20	-0.36%	-0.64%	+0.75%	+29.59%	46.13x	6.93x	+106.72%	+12.28%	+20.38%	+4.48%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.56%	-2.69%	+2.08%	-2.13%	-31.58x	2.36x	+9.51%	+2.96%	+5.96%	+55.56%	Strong Buy
Healthcare Plans	10	-0.12%	+1.21%	+5.01%	-15.66%	43.65x	2.07x	+12.19%	+3.78%	+9.23%	+14.08%	Buy
Health Information Services	54	-1.69%	-1.94%	-3.58%	-49.84%	42.11x	3.83x	+8.87%	+4.67%	+6.54%	+39.06%	Strong Buy
Medical Care Facilities	50	-1.25%	-1.53%	-4.54%	-42.75%	15.02x	5.23x	-80.60%	+7.33%	+16.04%	+20.06%	Buy
Medical Devices	139	+0.40%	-1.57%	-14.79%	-92.02%	23.79x	3.87x	+11.80%	+7.14%	+8.17%	+38.40%	Strong Buy
Medical Distribution	10	-0.79%	-0.70%	-3.80%	+44.38%	31.24x	3,562.64x	-56.46%	+3.41%	+21.83%	+9.05%	Buy
Medical Instruments & Supplies	57	-0.94%	-1.78%	+0.33%	-31.91%	222.67x	3.29x	+10.08%	+8.62%	+11.38%	+15.84%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock lose -23.93% over the past year, overperforming other healthcare stocks by 39 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -10.98% from Ironwood Pharmaceuticals's current stock price of $3.37.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #2 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 63.03% over the past year, overperforming other healthcare stocks by 126 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -0.27% from Pediatrix Medical Group's current stock price of $21.39.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: A.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 29, which is 3 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 75.56% over the past year, overperforming other healthcare stocks by 138 percentage points.

What are the healthcare stocks with highest dividends?

Out of 69 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.91%, which is 9 percentage points higher than the healthcare sector average of 1.92%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.48%, which is 8 percentage points higher than the healthcare sector average of 1.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.6%, which is 4 percentage points higher than the healthcare sector average of 1.92%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and down -1.76% over the last week. Corcept Therapeutics was the among the top losers in the healthcare sector, dropping -50.42% yesterday.

Corcept Therapeutics shares are trading lower after the company announced it received a Complete Response Letter for Relacorilant from the FDA.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -51.94% in the past year. It has overperformed other stocks in the healthcare sector by 11 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.75% in the past year. It has overperformed other stocks in the healthcare sector by 71 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -13.77% in the past year. It has overperformed other stocks in the healthcare sector by 49 percentage points.

Are healthcare stocks a good buy now?

57.52% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.56% over the next year.

7.72% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.81% of healthcare stocks are rated B (Buy), 47.84% are rated C (Hold), 24.68% are rated D (Sell), and 7.95% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 62.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.